The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma

Joji Nagasaki(Osaka City University), Hiroyoshi Nishikawa(Immunité et Cancer)
Blood Advances
September 1, 2020
Cited by 121


Related Papers